OncBioMune Pharmaceuticals, Inc (OBMP) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 15 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on May 7, 2020 involved a transaction of 166,667 shares valued at $10.0K.
No significant insider buying has been recorded for OBMP in the recent period.
No significant insider selling has been recorded for OBMP in the recent period.
Based on recent SEC filings, insider sentiment for OBMP is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at OncBioMune Pharmaceuticals, Inc (OBMP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading OBMP stock, having executed 15 transactions in the past 90 days. The most active insider is Andrew Albert Kucharchuk (Executive), who has made 2 transactions totaling $17.0K.
Get notified when executives and directors at OBMP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 7, 2020 | Frederick Head Jonathan | Executive | Award | 166,667 | $0.06 | $10.0K | |
| May 7, 2020 | Albert Kucharchuk Andrew | Executive | Award | 283,334 | $0.06 | $17.0K | |
| Mar 10, 2017 | Frederick Head Jonathan | Executive | Other | 2,892,000 | $N/A | $0 | |
| Mar 10, 2017 | Frederick Head Jonathan | Executive | Other | 2,892,000 | $N/A | $0 | |
| Feb 18, 2016 | S. Hoverman Daniel | Executive | Award | 60,000 | $N/A | $0 | |
| Nov 18, 2015 | L. Rice Charles Jr | Executive | Award | 60,000 | $N/A | $0 | |
| Nov 18, 2015 | L. Rice Charles Jr | Executive | Award | 60,000 | $N/A | $0 | |
| Sep 2, 2015 | Frederick Head Jonathan | Executive | Award | 500,000 | $N/A | $0 | |
| Sep 2, 2015 | Albert Kucharchuk Andrew | Executive | Award | 5,000,000 | $N/A | $0 | |
| Sep 2, 2015 | Lange Elliot Robert Jr | Executive | Sale | 1,025,000 | $N/A | $0 | |
| Sep 2, 2015 | Lange Elliot Robert Jr | Executive | Award | 17,951,079 | $N/A | $0 | |
| Sep 2, 2015 | Frederick Head Jonathan | Executive | Award | 17,951,078 | $N/A | $0 | |
| Sep 2, 2015 | Frederick Head Jonathan | Executive | Sale | 1,025,000 | $N/A | $0 | |
| Aug 27, 2015 | Ventures, Inc. American Capital | Executive | Other | 666,666 | $N/A | $0 | |
| Aug 27, 2015 | Llc Leone Group, | Executive | Other | 666,666 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 9 | $27.0K | 100.0% |
Other(J) | 4 | $0 | 0.0% |
Sale(S) | 2 | $0 | 0.0% |
Insider activity at OncBioMune Pharmaceuticals, Inc shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.7 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Andrew Albert Kucharchuk, has transacted $17.0K during this period.